Krey I, Platzer K, Esterhuizen A, Berkovic SF, Helbig I, Hildebrand MS et al (2022) Current practice in diagnostic genetic testing of the epilepsies. Epileptic Disord 24(5):1–22

Google Scholar 

Howell KB, Eggers S, Dalziel K, Riseley J, Mandelstam S, Myers CT et al (2018) A population-based cost-effectiveness study of early genetic testing in severe epilepsies of infancy. Epilepsia 59(6):1177–1187

Article  PubMed  PubMed Central  Google Scholar 

Papuc SM, Abela L, Steindl K, Begemann A, Simmons TL, Schmitt B et al (2019) The role of recessive inheritance in early-onset epileptic encephalopathies: a combined whole-exome sequencing and copy number study. Eur J Hum Genet 27(3):408–421

Article  CAS  PubMed  Google Scholar 

Symonds JD, Zuberi SM, Stewart K, McLellan A, O’Regan M, MacLeod S et al (2019) Incidence and phenotypes of childhood-onset genetic epilepsies: a prospective population-based national cohort. Brain 142(8):2303–2318

Article  PubMed  PubMed Central  Google Scholar 

Balestrini S, Chiarello D, Gogou M, Silvennoinen K, Puvirajasinghe C, Jones WD et al (2021) Real-life survey of pitfalls and successes of precision medicine in genetic epilepsies. J Neurol Neurosurg Psychiatry 92(10):1044–1052

Article  PubMed  Google Scholar 

Nabbout R, Kuchenbuch M (2020) Impact of predictive, preventive and precision medicine strategies in epilepsy. Nat Rev Neurol 16(12):674–688

Article  PubMed  Google Scholar 

Han Z, Chen C, Christiansen A, Ji S, Lin Q, Anumonwo C et al (2020) Antisense oligonucleotides increase Scn1a expression and reduce seizures and SUDEP incidence in a mouse model of Dravet syndrome. Sci Transl Med 12(558):eaaz6100

Article  PubMed  Google Scholar 

Carvill GL, Engel KL, Ramamurthy A, Cochran JN, Roovers J, Stamberger H et al (2018) Aberrant inclusion of a poison Exon causes Dravet syndrome and related SCN1A-associated genetic epilepsies. Am J Hum Genet 103(6):1022–1029

Article  CAS  PubMed  PubMed Central  Google Scholar 

Palmer EE, Schofield D, Shrestha R, Kandula T, Macintosh R, Lawson JA et al (2018) Integrating exome sequencing into a diagnostic pathway for epileptic encephalopathy: evidence of clinical utility and cost effectiveness. Mol Genet Genomic Med 6(2):186–199

Article  CAS  PubMed  PubMed Central  Google Scholar 

Palmer EE, Howell K, Scheffer IE (2021) Natural history studies and clinical trial readiness for genetic developmental and epileptic encephalopathies. Neurotherapeutics 18(3):1432–1444

Article  PubMed  PubMed Central  Google Scholar 

Jeffrey JS, Leathem J, King C, Mefford HC, Ross K, Sadleir LG (2021) Developmental and epileptic encephalopathy: Personal utility of a genetic diagnosis for families. Epilepsia Open 6(1):149–159

Article  PubMed  PubMed Central  Google Scholar 

Vears DF, Dunn KL, Wake SA, Scheffer IE (2015) ‘It’s good to know’: experiences of gene identification and result disclosure in familial epilepsies. Epilepsy Res 112:64–71

Article  CAS  PubMed  Google Scholar 

Helbig I, Heinzen EL, Mefford HC, the ILAE Genetics Commission (2016) Primer Part 1—The building blocks of epilepsy genetics. Epilepsia 57(6):861–868

Article  PubMed  Google Scholar 

Niemi MEK, Martin HC, Rice DL, Gallone G, Gordon S, Kelemen M et al (2018) Common genetic variants contribute to risk of rare severe neurodevelopmental disorders. Nature 562(7726):268–271

Article  CAS  PubMed  PubMed Central  Google Scholar 

Myers CT, Hollingsworth G, Muir AM, Schneider AL, Thuesmunn Z, Knupp A et al (2018) Parental mosaicism in “de novo” epileptic encephalopathies. N Engl J Med 378(17):1646–1648

Article  PubMed  PubMed Central  Google Scholar 

Møller RS, Liebmann N, Larsen LHG, Stiller M, Hentschel J, Kako N et al (2019) Parental mosaicism in epilepsies due to alleged de novo variants. Epilepsia. https://doi.org/10.1111/epi.15187

Article  PubMed  PubMed Central  Google Scholar 

Peljto AL, Barker-Cummings C, Vasoli VM, Leibson CL, Hauser WA, Buchhalter JR et al (2014) Familial risk of epilepsy: a population-based study. Brain 137(3):795–805

Article  PubMed  PubMed Central  Google Scholar 

International League Against Epilepsy Consortium on Complex Epilepsies (2018) Genome-wide mega-analysis identifies 16 loci and highlights diverse biological mechanisms in the common epilepsies. Nat Commun 9(1):5269

Article  Google Scholar 

Mirza N, Stevelink R, Taweel B, Koeleman BPC, Marson AG, International League Against Epilepsy Consortium on Complex Epilepsies (2021) Using common genetic variants to find drugs for common epilepsies. Brain Commun 3(4):fcab287

Article  PubMed  PubMed Central  Google Scholar 

Heyne HO (2022) Polygenic risk scores in epilepsy. Med Genet 34(3):225–230

Google Scholar 

Sánchez Fernández I, Gaínza-Lein M, Lamb N, Loddenkemper T (2019) Meta-analysis and cost-effectiveness of second-line antiepileptic drugs for status epilepticus. Neurology 92(20):e2339–e2348

Article  PubMed  Google Scholar 

Sheidley BR, Malinowski J, Bergner AL, Bier L, Gloss DS, Mu W et al (2022) Genetic testing for the epilepsies: A systematic review. Epilepsia 63(2):375–387

Article  PubMed  Google Scholar 

Borlot F, Regan BM, Bassett AS, Stavropoulos DJ, Andrade DM (2017) Prevalence of pathogenic copy number variation in adults with pediatric-onset epilepsy and intellectual disability. JAMA Neurol 74(11):1301

Article  PubMed  PubMed Central  Google Scholar 

Olson H, Shen Y, Avallone J, Sheidley BR, Pinsky R, Bergin AM et al (2014) Copy number variation plays an important role in clinical epilepsy. Ann Neurol 75(6):943–958

Article  CAS  PubMed  PubMed Central  Google Scholar 

Miller DT, Lee K, Gordon AS, Amendola LM, Adelman K, Bale SJ et al (2021) Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2021 update: a policy statement of the American College of Medical Genetics and Genomics (ACMG). Genet Med 23(8):1391–1398

Article  PubMed  Google Scholar 

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J et al (2015) Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 17(5):405–424

Article  PubMed  PubMed Central  Google Scholar 

Lewis-Smith D, Galer PD, Balagura G, Kearney H, Ganesan S, Cosico M et al (2021) Modeling seizures in the Human Phenotype Ontology according to contemporary ILAE concepts makes big phenotypic data tractable. Epilepsia 62(6):1293–1305

Article  PubMed  PubMed Central  Google Scholar 

Demarest ST, Brooks-Kayal A (2018) From molecules to medicines: the dawn of targeted therapies for genetic epilepsies. Nat Rev Neurol 14(12):735–745

Article  PubMed  Google Scholar 

Minardi R, Licchetta L, Baroni MC, Pippucci T, Stipa C, Mostacci B et al (2020) Whole-exome sequencing in adult patients with developmental and epileptic encephalopathy: It is never too late. Clin Genet 98(5):477–485

Article  CAS  PubMed  Google Scholar 

Benson KA, White M, Allen NM, Byrne S, Carton R, Comerford E et al (2020) A comparison of genomic diagnostics in adults and children with epilepsy and comorbid intellectual disability. Eur J Hum Genet 28(8):1066–1077

Article  PubMed  PubMed Central  Google Scholar 

Zacher P, Mayer T, Brandhoff F, Bartolomaeus T, Le Duc D, Finzel M et al (2021) The genetic landscape of intellectual disability and epilepsy in adults and the elderly: a systematic genetic work-up of 150 individuals. Genet Med 23(8):1492–1497

Article  CAS  PubMed  PubMed Central  Google Scholar 

Truty R, Patil N, Sankar R, Sullivan J, Millichap J, Carvill G et al (2019) Possible precision medicine implications from genetic testing using combined detection of sequence and intragenic copy number variants in a large cohort with childhood epilepsy. Epilepsia Open 4(3):397–408

Article  PubMed  PubMed Central  Google Scholar 

Syrbe S (2022) Developmental and epileptic encephalopathies—therapeutic consequences of genetic testing. Med Genet 34(3):215–224

Google Scholar 

Krey I, Platzer K, Lemke JR (2022) Monogenetic epilepsies and how to approach them in 2022. Med Genet 34(3):201–205

Google Scholar 

Stödberg T, Tomson T, Barbaro M, Stranneheim H, Anderlid BM, Carlsson S et al (2020) Epilepsy syndromes, etiologies, and the use of next-generation sequencing in epilepsy presenting in the first 2 years of life: a population-based study. Epilepsia 61(11):2486–2499

Article  PubMed  PubMed Central  Google Scholar 

Johannesen KM, Nikanorova N, Marjanovic D, Pavbro A, Larsen LHG, Rubboli G et al (2020) Utility of genetic testing for therapeutic decision-making in adults with epilepsy. Epilepsia 61(6):1234–1239

Article  PubMed  Google Scholar 

Krey I, Johannesen KM, Kohnen O, Lemke JR (2022) Genetic testing in adults with developmental and epileptic encephalopathy—what do we know? Med Genet 34(3):207–213

Google Scholar 

Klau J, Abou Jamra R, Radtke M, Oppermann H, Lemke JR, Beblo S et al (2022) Exome first approach to reduce diagnostic costs and time—retrospective analysis of 111 individuals with rare neurodevelopmental disorders. Eur J Hum Genet 30(1):117–125

Article  CAS  PubMed